Dashboard M. tuberculosis
Repurposing candidates for M. tuberculosis
Mycobacterium tuberculosis
Approved medicines with AI-predicted activity ≥40% against M. tuberculosis, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 1,072
- Existing antimicrobials set aside
- 128
- Needing review
- 74
- Repurposing candidates
- 870
Repurposing candidates for M. tuberculosis
AI prediction · nothing measuredAll 870 repurposing candidates for M. tuberculosis.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- ProtirelinExisting use: Tests for thyreoidea function55.8% AI-predicted activityagainst M. tuberculosis15 registered studies
- Vonoprazan FumarateExisting use: Gastroesophageal reflux disease, Peptic ulcer55.8% AI-predicted activityagainst M. tuberculosis24 registered studies
- LinagliptinExisting use: Diabetes mellitus, Type 2 diabetes mellitus55.7% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Brilliant Blue GExisting use: Disclosing Agent55.7% AI-predicted activityagainst M. tuberculosis10 registered studies
- AnidulafunginExisting use: Candidemia, Candidiasis, Peritonitis55.7% AI-predicted activityagainst M. tuberculosis43 registered studies
- Imatinib MesylateExisting use: Acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and 7 more55.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Propranolol HydrochlorideExisting use: Angina pectoris, Cardiac arrhythmia, Cardiovascular disease and 6 more55.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Rucaparib CamsylateExisting use: Cancer, Neoplasm, Ovarian cancer and 2 more55.6% AI-predicted activityagainst M. tuberculosis7 registered studies
- Alectinib HydrochlorideExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma55.4% AI-predicted activityagainst M. tuberculosis13 registered studies
- CarvedilolExisting use: Cardiovascular disease, Congestive heart failure, Heart failure and 3 more55.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- EfinaconazoleExisting use: Tinea, Tinea unguium55.4% AI-predicted activityagainst M. tuberculosis7 registered studies
- NifedipineExisting use: Cardiovascular disease, Coronary Vasospasm, Hypertension55.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Simeprevir SodiumExisting use: Chronic hepatitis C virus infection55.4% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- Valbenazine TosylateExisting use: Movement disorder55.4% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- Sodium Tetradecyl SulfateExisting use: Varicose veins55.3% AI-predicted activityagainst M. tuberculosis18 registered studies
- Daridorexant HydrochlorideExisting use: Insomnia55.2% AI-predicted activityagainst M. tuberculosis2 registered studies
- MidostaurinExisting use: Acute myeloid leukemia, Mast-cell leukemia, Mastocytosis and 2 more55.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Molindone HydrochlorideExisting use: Psychosis, Schizophrenia55.2% AI-predicted activityagainst M. tuberculosis8 registered studies
- RevefenacinExisting use: Airway obstruction, Chronic obstructive pulmonary disease55.2% AI-predicted activityagainst M. tuberculosis20 registered studies
- Olmesartan MedoxomilExisting use: Cardiovascular disease, Diabetes mellitus, Heart failure and 3 more55.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- AbrocitinibExisting use: Atopic eczema, Eczematoid dermatitis55.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Dabrafenib MesylateExisting use: Cancer, Cutaneous melanoma, Glioma and 3 more55.1% AI-predicted activityagainst M. tuberculosis24 registered studies
- RepaglinideExisting use: Diabetes mellitus, Type 2 diabetes mellitus55.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- RisdiplamExisting use: Atrophy, Proximal spinal muscular atrophy, Spinal muscular atrophy55.1% AI-predicted activityagainst M. tuberculosis33 registered studies